Encysive Pharmaceuticals Completes $60 Million Note Offering Secured by Argatroban Royalties
February 06, 2007 16:05 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that its newly formed, wholly-owned subsidiary has closed a private placement of $60 million in...
Encysive Pharmaceuticals Announces Presentation/Webcast At BIO CEO Conference
February 05, 2007 16:35 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 9th Annual BIO CEO & Investor Conference, taking place February...
Encysive Pharmaceuticals Announces Conference Call to Discuss Fourth Quarter and Year End 2006 Results
January 30, 2007 08:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 30, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Friday, March 9, 2007 at 8:00 a.m. ET to discuss its fourth quarter and year...
Encysive Pharmaceuticals Announces Presentation/Webcast At 25th Annual JPMorgan Healthcare Conference
January 04, 2007 08:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 4, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 25th Annual JPMorgan Healthcare Conference, taking place January 8-11,...
FDA Accepts Encysive's Complete Response to THELIN New Drug Application
December 28, 2006 13:53 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 28, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's complete...
Encysive Pharmaceuticals Announces Launch of Thelin in Germany
December 18, 2006 02:30 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 18, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets are now commercially available in Germany for...
Encysive Pharmaceuticals' THELIN (sitaxentan sodium) Receives Positive Opinion From Australian Health Authority
December 15, 2006 13:47 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 15, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the Australian Drug Evaluation Committee (ADEC) of the Therapeutic Goods Administration (TGA)...
Encysive Pharmaceuticals Submits Response to FDA For Thelin New Drug Application
December 14, 2006 21:03 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced it has provided the information requested by the U.S. Food and Drug Administration (FDA) in its letter...
Encysive Expects to Submit Revised Response to Thelin Approvable Letter Within Several Days
December 14, 2006 08:35 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) announced today that the U.S. Food and Drug Administration (FDA) informed the Company that its response to the...
Encysive Pharmaceuticals Receives FDA Clearance to Resume Clinical Studies With TBC3711
December 07, 2006 18:45 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 7, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate and resume...